McAbee G N
Department of Pediatrics, University of Medicine and Dentistry of New Jersey School of Osteopathic Medicine, Stratford 08084, USA.
J Am Osteopath Assoc. 1997 Jan;97(1):47-8. doi: 10.7556/jaoa.1997.97.1.47.
The US Supreme Court addressed the issue of expert medical and scientific testimony in the 1993 case Daubert v Merrell Dow Pharmaceuticals, Inc. The guidelines to be used as a standard for expert medical witnesses under Daubert differ from earlier standards used by many courts for more than 70 years. This commentary reviews the history of previous and current standards used to determine admissibility of medical testimony in legal proceedings and discusses the ramifications of these standards for osteopathic physicians involved in the medical malpractice process.
美国最高法院在1993年“道伯特诉美锐尔·陶氏制药公司案”中探讨了医学和科学专家证人的问题。根据“道伯特案”用作医学专家证人标准的指导方针，与许多法院使用了70多年的早期标准不同。本评论回顾了用于确定法律程序中医学证词可采性的以往和当前标准的历史，并讨论了这些标准对参与医疗事故处理过程的整骨疗法医生的影响。
